Registry study for children with primary ciliary dyskinesia
Part of Ear, nose & throat, Genetic & congenital, Lungs & breathing clinical trials.
This registry study collects medical information and samples from children who may have or have been diagnosed with primary ciliary dyskinesia (PCD). It helps researchers better describe the condition and its causes in Chinese children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child age 0 to 18 years old
- Your doctor suspects or confirms PCD (trouble with tiny hair-like cilia that help clear mucus) based on accepted diagnostic standards
- You have at least one abnormal test, such as abnormal cilia movement on special microscopy, abnormal cilia structure on electron microscopy, low nasal nitric oxide, or a target gene change
- You may also qualify if you show typical symptoms but only one test is positive (called “suspected” PCD registration)
- You (your guardian) can share complete medical records and your child can complete the diagnosis process
- You agree to participate and allow the study hospital to collect related specimens (samples)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information from people diagnosed with primary ciliary dyskinesia. It may help researchers better understand the condition over time and improve future care.
This study (RaDiCo-DCP) follows people who have a confirmed diagnosis of primary ciliary dyskinesia, a condition that can affect how your lungs clear mucus. The trial looks at long-term symptoms over time, which may help improve care planning and understanding of the condition.
This study looks at how the airways in people with primary ciliary dyskinesia (PCD) react to certain triggers. It aims to understand if these airways are more sensitive, which could help improve treatment for breathing problems.
This study invites people who have been told they may have, or who have confirmed, primary ciliary dyskinesia. It aims to better understand living with PCD and what helps people day to day.
This study checks whether using “PCD diagnostics” helps clinicians make better care decisions for people being evaluated for PCD. You might be able to join if you’re referred for PCD diagnosis and can complete the study steps.
This study tests whether a breathing test called nasal nitric oxide can help improve care for people with primary ciliary dyskinesia (PCD) or related lung/sinus problems. The goal is to see if the test can better guide diagnosis and treatment planning.
Hear when a new Primary Ciliary Dyskinesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.